【华润医药披露华润博雅生物一季度业绩】华润医药发布华润博雅生物截至 2025 年 3 月 31 日止 3 个月业绩,营业总收入 5.36 亿元人民币,同比增加 19.49%。净利润 1.39 亿元,同比减少 8.22%。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.